Bullzeye FinancialLog in

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM · Healthcare

₹4,869.00
as of 28 Sep 2026
AI verdict · 28 Sep 2026
Bullish 70% confidence

Strong Q1 FY27 results (54.6% sales growth, 33.8% EBITDA margin) and bullish EMA alignment validate JB Pharma integration; elevated 78.75x…

Strongest bull point

Q1 FY27 delivered 54.6% sales growth to ₹48.35 billion with 33.8% EBITDA margin, confirming JB Pharma integration success and India/Brazil organic momentum (15% and 30% YoY respectively).

Strongest bear point

Stock trades at extreme 78.75x TTM P/E with only one quarter of post-integration data; weak volume (0.91x 20-day average) and elevated leverage (2.3x net debt/EBITDA) signal execution risk.

Technical Forecast · next 10 trading days
Expected
₹4,716.65 -3.1%
Range
₹4,707.84 – ₹4,727.44
Technical Forecast Fundamental Debate

Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.

Every call on TORNTPHARM, misses included
  1. Bullish 28 Sep 2026 → now Scores 28 Oct 2026
    ₹4,869.00 → ₹4,869.00 0.0%
Our accuracy

Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.

How we score →
More Healthcare